93 related articles for article (PubMed ID: 25808443)
1. Study of NGEP expression pattern in cancerous tissues provides novel insights into prognostic marker in prostate cancer.
Mohsenzadegan M; Shekarabi M; Madjd Z; Asgari M; Abolhasani M; Tajik N; Farajollahi MM
Biomark Med; 2015; 9(4):391-401. PubMed ID: 25808443
[TBL] [Abstract][Full Text] [Related]
2. NGEP, a prostate-specific plasma membrane protein that promotes the association of LNCaP cells.
Das S; Hahn Y; Nagata S; Willingham MC; Bera TK; Lee B; Pastan I
Cancer Res; 2007 Feb; 67(4):1594-601. PubMed ID: 17308099
[TBL] [Abstract][Full Text] [Related]
3. Topology of NGEP, a prostate-specific cell:cell junction protein widely expressed in many cancers of different grade level.
Das S; Hahn Y; Walker DA; Nagata S; Willingham MC; Peehl DM; Bera TK; Lee B; Pastan I
Cancer Res; 2008 Aug; 68(15):6306-12. PubMed ID: 18676855
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis.
Mohsenzadegan M; Madjd Z; Asgari M; Abolhasani M; Shekarabi M; Taeb J; Shariftabrizi A
Cancer Immunol Immunother; 2013 Oct; 62(10):1609-18. PubMed ID: 23955683
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody against new gene expressed in prostate protein is traceable in prostate cancer patients.
Mohsenzadegan M; Saebi F; Yazdani M; Abolhasani M; Saemi N; Jahanbani F; Farajollahi MM
Biomark Med; 2018 Oct; 12(10):1125-1138. PubMed ID: 30191737
[TBL] [Abstract][Full Text] [Related]
6. Golgi Phosphoprotein-3 and Y-Box-Binding Protein-1 Are Novel Markers Correlating With Poor Prognosis in Prostate Cancer.
Abd El-Maqsoud NM; Osman NA; Abd El-Hamid AM; Fath El-Bab TK; Galal EM
Clin Genitourin Cancer; 2016 Apr; 14(2):e143-52. PubMed ID: 26794392
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
Engelhardt PF; Seklehner S; Brustmann H; Lusuardi L; Riedl CR
Scand J Urol; 2015 Apr; 49(2):120-6. PubMed ID: 25363611
[TBL] [Abstract][Full Text] [Related]
8. NGEP, a gene encoding a membrane protein detected only in prostate cancer and normal prostate.
Bera TK; Das S; Maeda H; Beers R; Wolfgang CD; Kumar V; Hahn Y; Lee B; Pastan I
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3059-64. PubMed ID: 14981236
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer antigen-1 as a potential novel marker for prostate cancer.
Liu BQ; Wu YD; Li PH; Wei JX; Zhang T; Liu RL
Asian J Androl; 2007 Nov; 9(6):821-6. PubMed ID: 17968469
[TBL] [Abstract][Full Text] [Related]
11. The expression of neuropeptides in hyperplastic and malignant prostate tissue and its possible clinical implications.
Yu DS; Hsieh DS; Chen HI; Chang SY
J Urol; 2001 Sep; 166(3):871-5. PubMed ID: 11490236
[TBL] [Abstract][Full Text] [Related]
12. STEAP1 protein overexpression is an independent marker for biochemical recurrence in prostate carcinoma.
Ihlaseh-Catalano SM; Drigo SA; de Jesus CM; Domingues MA; Trindade Filho JC; de Camargo JL; Rogatto SR
Histopathology; 2013 Nov; 63(5):678-85. PubMed ID: 24025158
[TBL] [Abstract][Full Text] [Related]
13. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
Väisänen MR; Väisänen T; Jukkola-Vuorinen A; Vuopala KS; Desmond R; Selander KS; Vaarala MH
Prostate; 2010 Jun; 70(8):817-24. PubMed ID: 20054821
[TBL] [Abstract][Full Text] [Related]
14. [Expression and significance of CD147 protein in prostate cancer].
He HC; Han ZD; Dai QS; Zou J; Zhang Y; Zhang Z; Liang YX; Ye YK; Chen ZN; Zhong WD
Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(26):1844-6. PubMed ID: 19953931
[TBL] [Abstract][Full Text] [Related]
15. pS2 (TFF1) expression in prostate carcinoma: correlation with steroid receptor status.
Abdou AG; Aiad HA; Sultan SM
APMIS; 2008 Nov; 116(11):961-71. PubMed ID: 19132993
[TBL] [Abstract][Full Text] [Related]
16. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K
Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
[TBL] [Abstract][Full Text] [Related]
17. CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer.
Zhong WD; Han ZD; He HC; Bi XC; Dai QS; Zhu G; Ye YK; Liang YX; Qin WJ; Zhang Z; Zeng GH; Chen ZN
Oncology; 2008; 75(3-4):230-6. PubMed ID: 18852494
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy.
Li T; Huang S; Dong M; Gui Y; Wu D
Urol Oncol; 2013 Nov; 31(8):1539-45. PubMed ID: 23089540
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues.
Yousef GM; Stephan C; Scorilas A; Ellatif MA; Jung K; Kristiansen G; Jung M; Polymeris ME; Diamandis EP
Prostate; 2003 Sep; 56(4):287-92. PubMed ID: 12858357
[TBL] [Abstract][Full Text] [Related]
20. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
